Andreas Halvorsen's position in BridgeBio Pharma is currently worth $696 Million. That's 2.46% of their equity portfolio (16th largest holding). The investor owns 13.41% of the outstanding BridgeBio Pharma stock. Andreas Halvorsen started to build up the position in BridgeBio Pharma in Q2 2019. Since then they sold 1.5 Million shares. The stake costed the investor $692 Million, netting the investor a gain of 0.5% so far.